HYPERTENSION CONTINUES to be one of the most common conditions treated by physicians. Ongoing research has better defined the mechanisms and clinical characteristics of this condition and enlarged the scope of therapeutic options. It is increasingly clear that high blood pressure, although an independent risk factor for adverse clinical events, frequently exists as part of a syndrome of cardiovascular, neuroendocrine, and metabolic abnormalities.1-3 Prognosis and appropriate treatment for the individual patient must, therefore, be based on considerations that go beyond blood pressure itself.
The Joint National Committee (JNC) on the Detection, Evaluation, and Treatment of High Blood Pressure has given opinions on the management of hypertension at 4-year intervals for almost 20 years. The recently published fifth report of the JNC (JNC V) concerning high blood pressure, presented as two separate and lengthy articles,4,5 offers detailed commentary on newer developments in the diagnosis and managementof hypertension, especially as
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 51
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.